Charles Schwab Investment Management Inc. Raises Position in Select Medical Holdings Co. (NYSE:SEM)

Charles Schwab Investment Management Inc. boosted its stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 1.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,646,320 shares of the health services provider's stock after purchasing an additional 24,439 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.27% of Select Medical worth $57,407,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in SEM. Hexagon Capital Partners LLC increased its position in Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider's stock valued at $27,000 after acquiring an additional 645 shares during the last quarter. Transcendent Capital Group LLC bought a new position in shares of Select Medical in the 2nd quarter worth approximately $35,000. Canada Pension Plan Investment Board purchased a new position in shares of Select Medical in the second quarter worth approximately $39,000. DekaBank Deutsche Girozentrale bought a new stake in Select Medical during the second quarter valued at approximately $60,000. Finally, GAMMA Investing LLC increased its holdings in Select Medical by 52.8% during the second quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider's stock valued at $70,000 after buying an additional 685 shares during the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Select Medical

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the firm's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now directly owns 22,000 shares of the company's stock, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 19.14% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on SEM. Royal Bank of Canada boosted their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a research report on Monday, November 4th. Benchmark lowered Select Medical from a "buy" rating to a "hold" rating in a report on Monday, November 25th. StockNews.com downgraded Select Medical from a "buy" rating to a "hold" rating in a research note on Thursday, November 21st. Finally, Bank of America started coverage on Select Medical in a research note on Tuesday, August 20th. They set a "buy" rating and a $42.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $40.75.

Select Medical Trading Up 3.7 %

Shares of SEM stock opened at $21.11 on Friday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The stock has a fifty day simple moving average of $34.11 and a two-hundred day simple moving average of $34.71. The firm has a market capitalization of $2.73 billion, a PE ratio of 9.86, a PEG ratio of 0.91 and a beta of 1.42. Select Medical Holdings Co. has a 52-week low of $20.00 and a 52-week high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last released its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter last year, the business posted $0.46 earnings per share. The firm's revenue was up 5.7% on a year-over-year basis. On average, analysts predict that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.37%. Select Medical's dividend payout ratio is 23.36%.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.